NAVB Navidea Biopharmaceuticals Inc
Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.
$1.90
As of 04/09/2021 IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 11/10/1992
Outstanding shares: 28,567,298
Average volume: 303,181
Market cap: $54,277,866
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
CUSIP: 63937X202
ISIN: US63937X2027
Sedol: BJHDL45
Valuation (See tab for details)
PE ratio: -4.77
PB ratio: 4.43
PS ratio: 59.32
Return on equity: -600.59%
Net income %: -863.53%